Evidence map›Paper›PMID 30918279›Full record

ArticleScientific reports2019

Sequential conditioning-stimulation reveals distinct gene- and stimulus-specific effects of Type I and II IFN on human macrophage functions.

Quen Cheng, Faraz Behzadi, Supriya Sen, Sho Ohta, Roberto Spreafico, Rosane Teles, Robert L Modlin, Alexander Hoffmann

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Transcriptional control of interferon-stimulated genes.The Journal of biological chemistry · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Quen ChengDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States.ORCID http://orcid.org/0000-0002-0161-1917
Faraz BehzadiDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States.
Supriya SenDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States.
Sho OhtaDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States.
Roberto SpreaficoDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States.
Rosane TelesDivision of Dermatology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, United States.
Robert L ModlinDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States.
Alexander HoffmannDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, 90095, United States. ahoffmann@ucla.edu.
University of California, Los Angeles · USQB3 · US

Funding

Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7M
TCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1990 to 2025
$10.4M
Vitamin D Metabolism in LeprosyP50AR063020 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2012 to 2016
$7.8M
Coordinated dynamic regulation and function of IRF transcription factorsR01AI132835 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOFFMANN, ALEXANDER · 2017 to 2021
$1.9M
NFkB Signaling in MacrophagesR01AI127864 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOFFMANN, ALEXANDER · 2017 to 2021
$1.9M
TRANSLATIONAL AIDS AND VIRAL PATHOGENESIS TRAINING (51)T32AI089398 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, OTTO O · 2010 to 2017
$1.6M
NIAID NIH HHS R01 AI022553NIAID NIH HHS R01 AI127864NIAID NIH HHS R01 AI132835NIAID NIH HHS T32 AI089398NIAMS NIH HHS P50 AR063020NIAMS NIH HHS R01 AR040312
6 · The paper itself

Abstract

Macrophages orchestrate immune responses by sensing and responding to pathogen-associated molecules. These responses are modulated by prior conditioning with cytokines such as interferons (IFNs). Type I and II IFN have opposing functions in many biological scenarios, yet macrophages directly stimulated with Type I or II IFN activate highly overlapping gene expression programs. We hypothesized that a sequential conditioning-stimulation approach would reveal with greater specificity the differential effects of Type I and II IFN on human macrophages. By first conditioning with IFN then stimulating with toll-like receptor ligands and cytokines, followed by genome-wide RNA-seq analysis, we identified 713 genes whose expression was unaffected by IFN alone but showed potentiated or diminished responses to a stimulus after conditioning. For example, responses to the cytokine TNF were restricted by Type II IFN conditioning but potentiated by Type I IFN conditioning. We observed that the effects of IFN were not uniformly pro- or anti-inflammatory, but highly gene-specific and stimulus-specific. By assessing expression levels of key signal transducers and characterizing chromatin accessibility by ATAC-seq, we identify the likely molecular mechanisms underlying Type I and Type II-specific effects, distinguishing between modulation of cytoplasmic signaling networks and the nuclear epigenome that synergistically regulate macrophage immune responses.

Indexed as

Cells, CulturedHigh-Throughput Nucleotide SequencingHumansInterferon-betaInterferon-gammaInterferon Type IMacrophagesPrincipal Component AnalysisRNA-SeqSignal TransductionTumor Necrosis Factor-alphaInterferon-betaInterferon-gammaInterferon Type ITumor Necrosis Factor-alpha

Identifiers

PMID30918279
PMCPMC6437173
OpenAlexW2924946681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.